Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nerivio Efficacy Under High-Frequency Use
Sponsor: Theranica
Summary
This is a Post-marketing study investigating the impact of frequant usage with Nerivio on the safety profile of Remote Electrical Neuromodulation (REN) for the treatment of migraine. This study assessed the safety and tolerability of REN when used at frequencies exceeding the labeled indication.
Official title: Safety Profile of High-Frequency Use of a Remote Electrical Neuromodulation (REN) Wearable Device for Migraine Treatment
Key Details
Gender
All
Age Range
8 Years - Any
Study Type
INTERVENTIONAL
Enrollment
2000
Start Date
2026-01-08
Completion Date
2026-01-30
Last Updated
2026-01-13
Healthy Volunteers
No
Conditions
Interventions
Nerivio (REN device)
Remote electrical neuromodulation (REN) device for the acute treatment of migraines. The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. The treatment is self-administered and controlled by a smartphone application
Locations (1)
Theranica USA Inc
Bridgewater, New Jersey, United States